Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective study of alafenamide tenofovir vs entecavir + sodium bicarbonate for hyperlacticemia in chronic hepatitis B
ChiCTR2000035861Phase 4Not yet recruiting
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Chronic Hepatitis B (CHB) and hyperlactataemia comparing entecavir + sodium bicarbonate with tenofovir alafenamide (2 arms). Primary endpoint: lactate normality rate. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
tenofovir alafenamideentecavir
03
Conditions
Chronic Hepatitis B (CHB)hyperlactataemia
Beyond the preview
Go deeper on ChiCTR2000035861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035861.